A vial is plastic or glass vessel or bottle, that is a small in size and used to store medication as powders, liquids, or capsules. Vials are also known as a phials or flacons. They can also be used as scientific samples or experimental vessels. There are various types of vials including single-dose vial and multi-dose vials which are used for medications. The single-dose vials are only used once while multi-dose vials can be used more than once. The vaccine vials are used to store vaccines to the temperature. Vaccine vials are used in medicine and in chemical laboratories. A vial has a bottle-like shape with a neck, or it can be tubular. The modern vials are habitually made from plastic or glass and used as storage for small quantities of liquid utilized in molecular biology applications or medical. A vial is a small-sized bottle that typically retains liquids. Modern vials are usually made with glass, polypropylene and other materials.
The various factors contributing to the growth of the global vaccine vials market are increasing production of vaccines, growing number of initiatives to promote immunization and rising awareness among the people regarding endemic diseases. Further, the booming medical research sector, surge in the geriatric population base, along with growing R&D investments in the field are creating lucrative opportunities for this industry to prosper. Alongside, growing prevalence of chronic and infectious diseases coupled with rising health cognizance among the masses are adding momentum to the progression of this business sphere. Moreover, increasing occurrence of airborne diseases, technological advancements in the field and emergence of potential players are augmenting the outlook of this marketplace.
This industry has been assessed using proven methodologies. Numerous market-centric aspects have been considered by the analysts for the granular assessment of this business sphere. In this report, 2020 is taken as the base year while 2021-2027 has been considered as the forecast duration.
The glass segment is expected to capture a high-volume share over the stipulated timeline. Borosilicate is the most commonly used glass type to manufacture vaccine vials. It is a type of glass that contains boron trioxide which allows for a very low coefficient of thermal expansion. Means that it will not break under extreme temperature changes as compared to regular glass. This glass is also well-known for its extremely high chemical resistance. This glass is invented in 1897 by Schott AG. The companies continuously producing borosilicate glass for pharmaceutical uses. For example, Schott and other pharma companies manufacture 50 billion borosilicate glass containers per year to transport vaccines and other medical products to patients worldwide. Currently, most vials used for pharmaceutical packaging are made of borosilicate glass. This type of glass has remained popular because it is chemically free, highly resistant to enzymes and is reasonably resistant to temperature changes.
The molded vials segment is reckoned to generate substantial returns over 2022-2028. Nowadays, moulded glass vials are in trends for manufacturing of vaccine vials. Moulded glass technology has been applied in the pharmaceutical industry mainly to reduce the cost and time of manufacturing of medical products. Also, it is used to improve the performance of drug devices. The molded glass vials are obtained by pouring molten glass into molds. Moulded glass vials are manufactured by cutting measured gobs from molten glass and feeding them into a mould. The vial shape is formed using a press and blow process or a blow and blow process. After the vial is made it is passed through an annealing lehr to reduce stress caused by the hot-forming process. Annealing lehr is a process of slowly cooling glass to release internal stresses after vails was formed. Moulded Type I borosilicate glass vials are suitable for a variety of pharmaceutical applications with injectable preparations.
The preventive vaccine segment is reckoned to amplify significantly over the forecast duration due to the increasing health cognizance of the masses along with the rising pervasiveness of chronic and infectious ailments.
The global vaccines vials market is expected to grow at a significant growth rate due to several driving factors, including-
The onset of the COVID-19 pandemic positively swayed the dynamics of the Worldwide Vaccine Vials Industry. With robust R&D activities, prominent biotechnology companies came up with effective vaccines aimed at the prevention of this infectious diseases. Governments pertaining to several nations implemented favourable policies to encourage the masses to get inoculated before it is too late. This escalated the demand for efficient vaccine vials for the secure storage of COVID-19 vaccines. It is worth noting that as of May 11th, 2021, an aggregate of 1,264,164,553 vaccine doses has been administered throughout the world
Vaccines vials are widely used in pharmaceutical packaging. The vaccines vial is a small container, cylindrical in shape can be used in such industries as the pharmaceutical, medical, environmental, and lab testing fields. It is used specifically to store medication as liquids, powders or capsules form. There are various types of vaccines vials available such as a single dose vial and multi-dose vials. Like as, the single dose vial is only used for once whereas a multi-dose vial can be used more than once respectively. The increasing investment in the glass vaccine vials, specifically in the pharmaceutical industry, growing production of vaccines and rising initiatives by government in biochemical industry are key impacting factors expected to drive the growth of vaccines vials market. Today, glass vials is creatively used for flexible aseptic filling throughout the medical, chemical, biological, and related fields for the containment of substances. Also, glass vials used for package pharmaceutical preparations that containing significant amounts of boric oxide, aluminium oxide, and alkali and/or alkaline earth oxides, benefits from high hydrolytic and thermal shock resistance.
Vaccine vials can be made using various types of glasses powered with various beneficial features. Some of them are mentioned below-
It is mostly used for pharmaceutical packaging. It is made of borosilicate glass that composed of silica (80 percent) and boric oxide (10 percent), with a small amount of sodium oxide and aluminium oxide. Borosilicate glass is a type of glass that is very popular because is reasonably resistant to temperature changes, chemically inert and highly resistant to enzymes. All these properties enable borosilicate vials to store drugs safely and prevent contamination. For example, Schott is one of the world's leading producers of pharmaceutical containers made from borosilicate glass. This is the most widely available material used to store and deliver vaccines and other sensitive medications. It is used by pharmaceutical companies with a unique combination of attributes to package biologic drugs while supporting today’s quality requirements of filling lines. It is recently used for doses of COVID-19 vaccines through 2021.
It is an injection vials that made out of type I borosilicate glass. It is a perfect container with a high process capability for critical features and improved delamination resistance. It is a product innovation that beats all known market requirements for a Type I borosilicate injection vial. It is available as bulk (non-sterile) or as ready to fill-version (sterile). This tubular glass meets all current requirements of the applicable ISO standards and pharmacopeias (USP and Ph.Eur.). Basically, it is ready to fill-injection vials which are produced according to cGMP, washed in a cleanroom, packed in tray or nest and tub and sterilized, ready to fill.
Valor glass is one example of a current innovations in pharmaceutical glassware. It is as aluminosilicate glass, the boric oxide of borosilicate glass is replaced with aluminium oxide that is designed to be stronger and more resistant to breakages than its predecessor. In addition, borosilicate glass breaks less than 20kg of force whereas valor glass is 50 times stronger, withstanding over 450kg before breaking. For example, In June 2020, Corning established a USD 204 million grant from the US government to expand manufacturing of its Valor vials for used in COVID-19 vaccines under the Operation Warp Speed initiative.
The molded glass vials are obtained by pouring molten glass into molds. This offers better thermal stability for the purpose of sterilization, enhanced transparency, superior impermeability, excellent barrier properties and chemical resistance, improved regulatory acceptance and lower environmental impact.
SG EZ-fill is the widest range of clean, sterile, dehydrogenated and ready to fill glass containers used in pharmaceutical industry. It allows the adoption of a unique fill & finish equipment for different packaging. SG EZ-fill Vial is a container which provide the highest level of quality, safety, and technology for the most demanding drugs.
A new hybrid vial by coating the inside of a medical grade plastic container with a nano-layer of pure silicon dioxide (SiO2). COVID-19 Vaccine For example, In 2020, The company launched a USD 163 million expansion project at its Auburn facility to increase the level production of its vaccine vial to supply the federal government with vials to support the COVID-19 vaccine effort. Also, In June, SiO2 Materials Science presented a grant by the US Government worth USD143 million, to allow them to manufacture their hybrid vials for use in COVID-19 vaccines. And, On September 22nd, 2020; SiO2, an advanced materials science company, and the government of Canada entered into a supply agreement for hybrid vials and syringes. The hybrid vials and syringes are a fusion of a plastic polymer exterior shell with a glass-like barrier coating on the inside. Both vials and syringes have been tested in cold temperature storage situations and are compatible down to -80 degrees Celsius. The vials and syringes will be filled in Canada and have been selected due to the flexibility and performance across a wide degree of thermal and supply chain situations.
The tubular injectable glass vials are obtained by using glass tube by hot edges for filling antibiotics vaccine. Tubular glass vials are hot-formed from a continuous length of Type I glass tubing. It is used as automatic inspection system to control appearance and tolerance. It is made of borosilicate glass with high-quality glass tubing with crimp neck finish. The main application of these vials is for the packaging of penicillin, vaccine, injection powders, and lyophilized powder. It is available with rubber stoppers, aluminum caps.
This Vials has stable physical and chemical properties, good compatibility with the contained drugs, strong thermal shock resistance, cold resistance, acid and alkali resistance. It is used for directly filling injection and sterile powder for injection.
It provides drug stability in particular for sensitive drugs and drugs with low-filling volumes. An EVERIC Pure vial allows drug stability by using FIOLAX CHR (controlled hydrolytic resistance) glass tubing, which has a higher chemical stability than standard borosilicate glass without any change in composition. EVERIC pure is a new borosilicate glass vials ensure drug stability by using an improved borosilicate glass tubing a new generation of ultra-pure pharmaceutical vials to meet the exacting drug stability needs of low-fill drugs. It is used for sensitive drugs and drugs with low filling volumes. It is ISO certified and available in 2 ml -20 ml size capacity.
This vial presenting the chemical stability of the medical blended silicone oil makes the glass bottle hydrophobic that can help to reduce the residual on the wall of the glass bottle and avoid the waste of the medicine. It is suitable for specific pharmaceuticals such as suspensions, protein absorption drug injections. By using a special process on vials to form a layer of ultra-thin and dense uniform film on the inner wall of the glass container to seal and shield. It can help to allows the consistency of the pharmaceutical and minimized the interactions between the products and the glass container. It is ideal for biopharma, high value vaccine and sensitive drugs such as pharmaceutical, ophthalmology, laboratory, cosmetic etc. Full automated siliconization technology is used to prepare siliconized glass vials.
Asia Pacific- It is anticipated to witness the fastest growth in vaccines vials market during the forecast period. This is mainly due to the high prevalence of infectious diseases increasing throughout the Asia Pacific. For instance; according to the World Health Organization April 2021, in China, there are around 572,257 total specimens processed of Influenza A and B, in Cambodia, there are around 1,116 and in Singapore, there are 2,578 total number specimens processed of Influenza A and B. Also, according to The Print in June 2020, India informed the highest number of 24.04 lakh tuberculosis cases as against an expected 26.9 lakh cases by WHO. The rapidly increasing infectious diseases in the Asia Pacific is the reason for the death of people while being vaccinated is the safest way to avoid affecting infectious diseases. The demand for vaccines and ultimately vaccine vials is enhancing in the Asia Pacific.
Middle East & Africa- This region is poised to generate significant returns over the stipulated timeframe. This is ascribed to the growing prevalence of chronic and infectious ailments, rising efforts of concerned bodies to promote immunization among the masses by eradicating fear and taboo associated with vaccine administration, along with surge in the geriatric population base. Further, emergence of prominent players, booming pharmaceutical packaging sector, increasing health awareness among individuals, and rising healthcare expenditure are contributing to the growth of this regional market.
|Historical data||2018 - 2021|
|Forecast Period||2022 - 2028|
|Market Size in 2021:||USD 102.03 Million|
|Base year considered||2020|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD 114.69 Million|
|Tables, Charts & Figures:||175|
|Vaccine Vials Companies||Anhui Huaxin Medicinal Glass Products Co., Ltd., Berlin Packaging LLC, Cardinal Health, Inc., Catalent, Inc., Corning Inc., DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co., Ltd., JOTOP Glass, Nipro Corporation, Origin Pharmaceuticals Ltd, Pacific Vial Manufacturing Inc., Qorpak, Inc., Richland Glass Company, Inc., VMD SOLUTIONS, J&J, BARDA, The Serum Institute of India, Fujifilm Diosynth Biotechnologies, Lonza, others.|
|Segments Covered||By Type, By Material, By Technology, By Application, By Capacity|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|